Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 68788-4010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 68788-4010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion Hydrochloride Extended-release Tab Xl 150mg (Bupropion 150mg 30s)

Bupropion Hydrochloride Extended-release Tab Xl 150mg (Bupropion 150mg 30s)
Label for Bupropion Hydrochloride Extended-Release Tablets (XL) 150 mg by Preferred Pharmaceuticals Inc. The label indicates it is a generic for Wellbutrin XL, with dosage form and strength clearly stated. The manufacturer is Granules India Limited. Includes bilingual instructions for use, barcode, and caution about federal law prohibiting transfer to others.*
FDA Label Image

Bupropion-structure.jpg (Bupropion Structure)

Bupropion-structure.jpg (Bupropion Structure)
Chemical structure of bupropion hydrochloride showing a chlorophenyl ring bonded to a keto and amine group with methyl substituents, representing the active ingredient bupropion hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.